---
id: ITE-2023-118
type: ITE
year: 2023
number: 118
created: 2025-08-08 10:07:36.938200
tags:
- ITE
- question
- ITE-2023
answer: D
topic: null
related_articles:
- title: Screening for Anxiety, Depression, and Suicide Risk in Children and Adolescents.
  path: 2024/2024-07-screening-for-anxiety-depression-and-suicide-risk-in-childre.md
  similarity: 0.8
  link: '[[2024/2024-07-screening-for-anxiety-depression-and-suicide-risk-in-childre|Screening
    for Anxiety, Depression, and Suicide Risk in Children and Adolescents.]]'
- title: Screening for Lipid Disorders in Children and Adolescents.
  path: 2024/2024-09-screening-for-lipid-disorders-in-children-and-adolescents.md
  similarity: 0.667
  link: '[[2024/2024-09-screening-for-lipid-disorders-in-children-and-adolescents|Screening
    for Lipid Disorders in Children and Adolescents.]]'
- title: Bupropion for Depression in Adolescents.
  path: 2024/2024-07-bupropion-for-depression-in-adolescents.md
  similarity: 0.667
  link: '[[2024/2024-07-bupropion-for-depression-in-adolescents|Bupropion for Depression
    in Adolescents.]]'
- title: 'Firearm Injury Prevention: Practical Office Tips.'
  path: 2024/2024-05-firearm-injury-prevention-practical-office-tips.md
  similarity: 0.625
  link: '[[2024/2024-05-firearm-injury-prevention-practical-office-tips|Firearm Injury
    Prevention: Practical Office Tips.]]'
- title: Screening and Preventive Interventions for Oral Health in Children, Adolescents,
    and Adults.
  path: 2024/2024-03-screening-and-preventive-interventions-for-oral-health-in-ch.md
  similarity: 0.556
  link: '[[2024/2024-03-screening-and-preventive-interventions-for-oral-health-in-ch|Screening
    and Preventive Interventions for Oral Health in Children, Adolescents, and Adults.]]'
topics:
- Psychiatry
---

# Question ITE-2023-118

A 9-year-old male has persistent severe depression despite cognitive behavioral therapy. Which one of the following medications is approved by the FDA for the treatment of major depressive disorder in this age group?

## Options

**A.** No antidepressant medications

**B.** Bupropion (Wellbutrin)

**C.** Escitalopram (Lexapro)

**D.** Fluoxetine (Prozac)

**E.** Sertraline (Zoloft)

## Answer

**D**

## Explanation

Only two medications, escitalopram and fluoxetine, are approved by the FDA for the treatment of major depressive disorder in children and adolescents. Fluoxetine is approved for treatment in children age 8 while escitalopram is only approved for use in children age 12. Bupropion and sertraline are not approved by the FDA for the treatment of major depressive disorder in children.

## References

Selph SS, McDonagh MS. Depression in children and adolescents: evaluation and treatment. Am Fam Physician . 2019;100(10):609-617.
